Document is current
Any future updates will be listed below
-
Authors
Zabihi, Mohsen
Hoseinzadeh, Farahnaz
Mostafaei, Mahla
Vahedian-Ardakani, Hassan-Ali
Saghafi, Fatemeh
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct20191106045356n6 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
Curcumin as a neuroprotective agent against platinum-induced peripheral neuropathy: a double-blind randomized clinical trial
https://doi.org/10.1007/s12672-026-05128-4
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 28 April 2026
First Online: 11 May 2026
Declarations
:
: The study protocol was approved by the Ethics Committee of Shahid Sadoughi University of Medical Sciences, Yazd, Iran (Ethics code: IR.SSU.MEDICINE.REC.1400.134). All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the Declaration of Helsinki. Patient confidentiality was strictly maintained throughout the study. Written informed consent was obtained from all participants prior to enrollment in the study.
: Not applicable.
: The authors declare no competing interests.
